Skip to main content

RESMED INC

For the period ended Jun 30, 2024. Filed Aug 9, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Aug 9, 2024

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

PART IVSignatures
RESMED INC. AND SUBSIDIARIES

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DATED August 8, 2024

ResMed Inc.

/s/ MICHAEL J. FARRELL

Michael J. Farrell

Chief Executive Officer

(Principal Executive Officer)

-106-

PART IVSignatures
RESMED INC. AND SUBSIDIARIES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

SIGNATURETITLEDATE
/S/ MICHAEL J. FARRELLChief Executive Officer and ChairmanAugust 8, 2024
Michael J. Farrell(Principal Executive Officer)
/S/ BRETT A. SANDERCOCKChief Financial OfficerAugust 8, 2024
Brett A. Sandercock(Principal Financial Officer andPrincipal Accounting Officer)
/S/ PETER C. FARRELLDirector and Chair EmeritusAugust 8, 2024
Peter C. Farrell
/S/ CAROL J. BURTDirectorAugust 8, 2024
Carol J. Burt
/S/ JAN De WITTEDirectorAugust 8, 2024
Jan De Witte
/S/ KAREN DREXLERDirectorAugust 8, 2024
Karen Drexler
/S/ HARJIT GILLDirectorAugust 8, 2024
Harjit Gill
/S/ JOHN HERNANDEZDirectorAugust 8, 2024
John Hernandez
/S/ RICHARD SULPIZIODirectorAugust 8, 2024
Richard Sulpizio
/S/ DESNEY TANDirectorAugust 8, 2024
Desney Tan
/S/ RON TAYLORDirectorAugust 8, 2024
Ron Taylor

-107-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.